Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 9.58 Billion | USD 17.33 Billion | 6.11% | 2024 |
The global structural heart imaging market size was worth around USD 9.58 Billion in 2024 and is predicted to grow to around USD 17.33 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 6.11% between 2025 and 2034. The report analyzes the structural heart imaging market’s drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the structural heart imaging market.
Structural heart imaging (SHI) is an imaging technique that uses a high-resolution camera to screen the heart to produce clear images that help doctors accurately diagnose a patient’s heart condition. Echocardiography and angiography (MRI, CT, etc.) are the most widely used structural imaging modalities to evaluate cardiac structure and identify narrowing or blockage of blood vessels. The key factors that are expected to drive the growth of the global structural heart imaging market during the forecast period are the increasing prevalence of cardiac heart disease (CHD) globally. In addition, increasing advances in imaging modality technology are expected to drive the growth of the structured heart imaging market. In addition, increasing knowledge about heart diseases, including high blood pressure, could reduce the development of the structured heart imaging (SHI) market.
On the other hand, rising costs are expected to hinder the growth of the structured heart imaging market during the forecast period. Furthermore, the increasing acceptance of advanced devices will present more potential opportunities for structural heart imaging market growth in the coming years. However, inadequate return policies may still challenge the development of the structured heart imaging (SHI) market in the near future.
The COVID-19 pandemic has impacted the businesses of structural heart imaging. The COVID-19 pandemic spread throughout the world as strict lock-downs are implemented by governments and shut down companies. Thus, the movement of people is restricted during the Covid-19 pandemic; the global structural heart imaging market is likely to be impacted considerably during the forecast period. Besides that, the limited use of these procedures affected the market growth during the pandemic period.
The increasing prevalence of CHD aids the global market growth
The global structural heart imaging market is mainly driven by factors such as the increasing prevalence of cardiac heart disease (CHD) worldwide, the rising development in imaging modality technology, and growing awareness of heart diseases such as high blood pressure. According to an article published by the Centers for Disease Control and Prevention, in 2019, coronary heart disease affects about 1% of approximately 40,000 births annually, and about 100 to 200 deaths occur yearly due to undetected heart disease in infants in the USA. As a result, the demand for cardiac structural imaging is also increasing, contributing to the growth of the global market.
The strict regulatory guidelines may hamper the global market growth
The key restraints for the global structural heart imaging market are the stringent regulatory guidelines for equipment used in cardiac structural imaging, lack of awareness of cardiac-specific structural imaging, and higher cost are some of the factors the market is expected to hinder market growth.
The technological advancement in structural heart imaging by market players brings up several growth opportunities
Structural intervention in heart disease is a revolutionary breakthrough that has replaced open surgery and enabled more patients to be treated at a reduced cost. Significant advances have been made in structural cardiac interventions over the past decade. Advances in procedure and imaging are closely linked, from transcardiac aortic and pulmonary valve replacement to left atrial appendage occlusion procedures and mitral repair techniques percutaneous and, more recently, mitral valve replacement with transcardiocentesis & tricuspid intervention.
For instance, the commercial availability of three-dimensional (3D) echocardiography has improved edge-to-edge repair techniques' efficiency, accuracy, and adaptability. The collaboration of ultrasound and equipment companies continues to produce breakthroughs in imaging that can contribute to devising innovation, partly to imaging groups such as the Ultrasonic Society. U.S. echocardiography. Because of the imaging-intensive nature of all these procedures, the radiographer must be familiar with many of the anatomical goals and modern imaging techniques and perform a variety of procedural interventions. Cameras have proven to be crucial to the continued advancement of the field because of this information base. Therefore, the market is expected to offer opportunities from the abovementioned factors during the forecast period.
The global structural heart imaging market is segregated based on imaging modality, procedure type, application, end-user, and region.
By imaging modality, the market is divided into echocardiograms and angiograms. Among these, the angiogram segment dominated in 2021. Growth of this segment is favored as demand for different imaging modalities is expected to increase due to the increased diagnostic demand and effective imaging for detecting SHD, especially CHD.
By procedure type, the market is bifurcated into transcatheter aortic valve replacement (TAVR), surgical aortic valve replacement (SAVR), transcatheter mitral valve repair (TMVR), left atrial appendage closure (LAAC), annuloplasty, valvuloplasty, and others. Over the forecast period, the transcatheter aortic valve replacement (TAVR) segment is expected to account for the largest share of revenue during the forecast period. The growth of this segment is mainly due to the increasing number of TAVR procedures being implemented worldwide, the durability and long-term effects of these products, and favorable regulatory policies for their use of these devices.
Report Attributes | Report Details |
---|---|
Report Name | Structural Heart Imaging Market |
Market Size in 2024 | USD 9.58 Billion |
Market Forecast in 2034 | USD 17.33 Billion |
Growth Rate | CAGR of 6.11% |
Number of Pages | 288 |
Key Companies Covered | Siemens Healthcare GmbH, Koninklijke Philips N.V., Fujifilm Holdings, GE Healthcare, Abbott Laboratories, Boston Scientific Corporation, Circle Cardiovascular Imaging Inc., Edwards Lifesciences Corporation, Integer Holdings Corporation, Lepu Medical Technology Co. Ltd., LivaNova PLC, Medtronic plc, Pie Medical Imaging B.V., and others. |
Segments Covered | By Imaging Modality, By Procedure Type, By End User, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA) |
Base Year | 2024 |
Historical Year | 2020 to 2023 |
Forecast Year | 2025 - 2034 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The growing number of patients and presence of market players help North America dominate the global market
In 2021, North America dominated the global structural heart imaging market with the highest market revenue share. The incidence of congenital heart defects is increasing; there is a growing need for enhanced technology to treat structural heart disease, increasing adoption of lifestyle changes, growing awareness of structural illnesses, more preventive care, favorable government policies, clinical trials and product introductions by significant players in the region are some of the factors that will drive market growth during the forecast period. For example, according to the Centers for Disease Control and Prevention, the most common congenital disabilities are congenital heart defects, and babies are born with these problems.
Coronary artery disease affects nearly 1% of births or about 40,000 births annually in the United States. Some coronary heart diseases, especially mild forms, are increasing in prevalence (number of babies born with heart defects divided by the total number of babies born). At the same time, rates for other types are unchanged. A ventricular septal defect (VSD) is the most common type of heart defect. 1 out of 4 newborns has acute coronary artery disease. Newborns with severe coronary heart disease often need surgery or other procedures during their first year. Therefore, the North American region is expected to hold the largest market share during the forecast period because of the abovementioned factors.
The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the structural heart imaging market on a global and regional basis.
Some of the main competitors dominating the global structural heart imaging market include -
By Imaging Modality
By procedure type
By Application
By End-user
By Region
FrequentlyAsked Questions
The global structural heart imaging market is expected to grow due to rising prevalence of heart valve diseases, growth in minimally invasive procedures, and advances in 3D/4D imaging technologies.
According to a study, the global structural heart imaging market size was worth around USD 9.58 Billion in 2024 and is expected to reach USD 17.33 Billion by 2034.
The global structural heart imaging market is expected to grow at a CAGR of 6.11% during the forecast period.
North America is expected to dominate the structural heart imaging market over the forecast period.
Leading players in the global structural heart imaging market include Siemens Healthcare GmbH, Koninklijke Philips N.V., Fujifilm Holdings, GE Healthcare, Abbott Laboratories, Boston Scientific Corporation, Circle Cardiovascular Imaging Inc., Edwards Lifesciences Corporation, Integer Holdings Corporation, Lepu Medical Technology Co. Ltd., LivaNova PLC, Medtronic plc, Pie Medical Imaging B.V., among others.
The report explores crucial aspects of the structural heart imaging market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed